Dr Marlies Wijsenbeek
Dr Marlies Wijsenbeek Centre of Interstitial Lung Diseases, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands Marlies Wijsenbeek is a pulmonary physician at the Erasmus MC [...]
Dr Marlies Wijsenbeek Centre of Interstitial Lung Diseases, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands Marlies Wijsenbeek is a pulmonary physician at the Erasmus MC [...]
Professor Toby Maher Toby Maher is Professor of Medicine and Director of Interstitial Lung Disease at Keck School of Medicine, University of Southern California, Los Angeles. He has spent the [...]
Professor Kevin R. Flaherty Dr. Kevin R. Flaherty is a Professor of Medicine in the Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine at the University of Michigan [...]
Professor Surinder Birring Surinder Birring is Professor of Respiratory Medicine and Consultant Respiratory Physician at King’s College Hospital, London (specialist clinics in ILD, Cough [...]
Professor Michael Tharp, MD Michael D. Tharp, MD is Clark W. Finnerud, M.D. Professor and Chair of the Department of Dermatology at Rush University Medical Center. Dr. Tharp graduated cum laude [...]
Martin Metz Martin Metz is Professor of Dermatology with focus on pruritus research at the Department of Dermatology and Allergy, Charité – Universitätsmedizin Berlin, Germany. He received his [...]
Sonja Ständer, MD Sonja Ständer is professor for Dermatology and Neurodermatology at the Department of Dermatology, and head of the Interdisciplinary Competence Center Chronic Pruritus (KCP) of [...]
Professor Jaclyn Smith Jacky Smith is a Professor of Respiratory Medicine at the University of Manchester and an Honorary Consultant at the University Hospital of South Manchester NHS Foundation [...]
Dr Mandel Sher Dr. Mandel Sher is a Professor of Medicine and Pediatrics at the University of South Florida, Division of Allergy & Immunology. As USF faculty at Johns Hopkins All Children’s [...]
NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
More information about our Cookie Policy